{"retweeted":false,"source":"<a href=\"http://twitter.com\" rel=\"nofollow\">Twitter Web Client</a>","entities":{"hashtags":[],"symbols":[],"user_mentions":[{"name":"Ivan Kirigin","screen_name":"ikirigin","indices":["0","9"],"id_str":"4106551","id":"4106551"}],"urls":[]},"display_text_range":["0","132"],"favorite_count":"0","in_reply_to_status_id_str":"646001464213553156","id_str":"646002897860214784","in_reply_to_user_id":"4106551","truncated":false,"retweet_count":"0","id":"646002897860214784","in_reply_to_status_id":"646001464213553156","created_at":"Mon Sep 21 16:47:47 +0000 2015","favorited":false,"full_text":"@ikirigin i'm under the impression IP rights for drugs are very short. and people don't recreate because of development costs. true?","lang":"en","in_reply_to_screen_name":"ikirigin","in_reply_to_user_id_str":"4106551"}